Abstract: A method for or treating respiratory disease according to an embodiment includes administering to a subject in need thereof an extract of Siraitia grosvenorii residuals as an effective component. The extract of Siraitia grosvenorii residuals has, in an animal model having asthma induced by ovalbumin (OVA), an effect of reducing airway hyper-responsiveness, inhibiting inflammatory cells in bronchoalveolar lavage fluid (BALF), reducing Th2 cytokines (IL-4, IL-5, and IL-13) in BALF, reducing inflammation and tissue damage in lung tissues, inhibiting contraction of airway smooth muscle and airway inflammation, an effect of inhibiting expression of IL-13, TARC, TNF-?, IL-17, and MUC5AC, which is a gene encoding mucus protein, in lung tissues, an effect of reducing the level of ovalbumin-specific IgE in blood serum, and an effect of reducing ROS in alveolar cells which is generated in excess amount due to fine dust.

Abstract: The present invention relates to a composition for preventing, ameliorating, or treating hyperuricemia or metabolic disorders related with hyperuricemia comprising an extract of Alpinia oxyphylla as an effective ingredient. Because the extract of Alpinia oxyphylla of the present invention can reduce the uric acid amount in blood of an animal model and is derived from natural products, and the raw materials can be easily obtained, it can be widely used in industries that are related to hyperuricemia or metabolic disorders related with hyperuricemia. It can be effectively used for prevention, amelioration, or treatment of gout or gouty arthritis, in particular.

Abstract: The present invention relates to a composition for preventing, ameliorating, or treating hyperuricemia or metabolic disorders related with hyperuricemia comprising an extract of Alpinia oxyphylla as an effective ingredient. Because the extract of Alpinia oxyphylla of the present invention can reduce the uric acid amount in blood of an animal model and is derived from natural products, and the raw materials can be easily obtained, it can be widely used in industries that are related to hyperuricemia or metabolic disorders related with hyperuricemia. It can be effectively used for prevention, amelioration, or treatment of gout or gouty arthritis, in particular.

Abstract: An electrode composition, an electrode, and a solar cell, the composition including a conductive powder; glass frit; an organic binder; and a solvent, wherein the organic binder is a compound that includes a moiety represented by Chemical Formula 1:

Abstract: A composition for a transparent electrode according to the present invention comprises (A) a carbon nanotube dispersing solution and (B) a metal nanowire solution having a zeta potential with the same polarity as the carbon nanotube dispersing solution, and a transparent electrode coated with the composition for the transparent electrode has superior transmittance, electrical conductivity and transparency.

Abstract: A composition for solar cell electrodes, the composition including silver (Ag) powder; a glass frit; an organic binder; and a solvent, the organic binder including a compound containing a repeat unit represented by Formula 1: wherein R1 is Na+, K+, NH4+, or PH3+; R2 is a hydrogen atom or a C1 to C2 alkyl group; and n is an integer of 1 to 3,500.

Abstract: An electrode composition, an electrode, and a solar cell, the composition including a conductive powder; glass frit; an organic binder; and a solvent, wherein the organic binder is a compound that includes a moiety represented by Chemical Formula 1:

Abstract: A composition for solar cell electrodes, the composition including silver (Ag) powder; a glass frit; an organic binder; and a solvent, the organic binder including a compound containing a repeat unit represented by Formula 1: wherein R1 is Na+, K+, NH4+, or PH3+; R2 is a hydrogen atom or a C1 to C2 alkyl group; and n is an integer of 1 to 3,500.

Abstract: A composition for a transparent electrode according to the present invention comprises (A) a carbon nanotube dispersing solution and (B) a metal nanowire solution having a zeta potential with the same polarity as the carbon nanotube dispersing solution, and a transparent electrode coated with the composition for the transparent electrode has superior transmittance, electrical conductivity and transparency.

Abstract: Disclosed is a temperature control apparatus having a new structure capable of enhancing efficiency by reducing evaporation of a thermal medium at a high temperature and extending a life span of a heat exchanger.

Abstract: The present invention provides a stacked transparent electrode in which a coating layer (B) comprising carbon nanotubes and a coating layer (C) comprising metal nanowires are stacked on a base substrate (A) in a plurality of levels, wherein the stacked structure is composed of the coating layer (B) comprising carbon nanotubes and the coating layer (C) comprising metal nanowires stacked in an alternate manner, further the present invention can maximize the conductivity of the metal nanowire by coating the transparent substrate using the carbon nanotubes and the metal nanowires, and can secure efficiency and stability of the transparent electrode by preventing oxidation of the metal nanowires and maintaining a stable coating surface when coupled with the carbon nanotubes.

Abstract: A thermoplastic resin composition that can have excellent EMI shielding and injection-molding processability includes (A) a thermoplastic resin, (B) carbon fibers, and (C) filler comprising nano metal particles surface coated with graphite crystalline nano carbon particles, composite fillers which are carbon nanotubes coated with nano metal particles, composite fillers which are carbon nanotubes supporting nano metal particles, and combinations thereof.

Abstract: Disclosed herein are an electromagnetic wave shielding thermoplastic resin composition and a plastic article including the same. The electromagnetic wave shielding thermoplastic resin composition comprises about 100 parts by weight of a thermoplastic resin comprising a polycarbonate resin, a polyester resin, or a combination thereof, about 1 to about 30 parts by weight of stainless steel fiber, and about 0.01 to about 10 parts by weight of carbon nanotubes.

Abstract: The present invention relates to a method for manufacturing carbon nanotubes comprising: a preparatory step of a supported catalyst; a temperature-raising step of inserting the supported catalyst into a reactor, injecting hydrocarbon gas and hydrogen gas at the same time, and raising the temperature of the reactor to between 900 to 1000° C. to synthesize carbon nanotubes; and a temperature-lowering step of lowering the temperature of the reactor to between a room temperature to 200° C., injecting only hydrogen gas, and synthesizing carbon nanotubes. The carbon nanotubes manufactured by the above method have high purity, and excellent selectivity for double wall carbon nanotubes can be achieved.

Abstract: Disclosed herein is a method of fabricating a transparent conductive film, including preparing a carbon nanotube composite composition by blending a carbon nanotube in a solvent; coating the carbon nanotube composite composition on a base substrate to form a carbon nanotube composite film, and acid-treating the carbon nanotube composite film by dipping the carbon nanotube composite film in an acid solution, followed by washing the carbon nanotube composite film with distilled water and drying the washed carbon nanotube composite film to form a transparent electrode on the base substrate. The transparent conductive film can have excellent conductivity, transparency and bending properties following acid treatment, so that it can be used in touch screens and transparent electrodes of foldable flat panel displays. Further, the carbon nanotube composite conductive film can have improved conductivity while maintaining transparency after acid treatment.

Abstract: Provided is a composition that, even when used in a very small amount, has the effect of improving bone density and promoting bone growth, and has few side effects, and also provided are a pharmaceutical preparation for promoting bone growth, functional food product, and health food product containing the composition as an active ingredient. The composition can be obtained from any plant part selected from the group consisting of the bud, leaf, bark or wood of a plant belonging to the family Magnoliaceae. The composition comprises at least one selected from the group consisting of fargesin and physiologically acceptable salts, hydrates, and glycosides thereof. The pharmaceutical preparation, functional food product, and health food product comprising this composition as an active ingredient sufficiently improve bone density and promote bone growth, even when used in small amounts, and therefore realize preventive and/or therapeutic effects against bone disease etc. such as osteoporosis.

Abstract: The present invention provides a polycarbonate resin composition comprising a polycarbonate (A), a styrene copolymer resin (B), carbon nano-tubes (C) and a carbon black (D).

Abstract: Disclosed herein is a method of fabricating a transparent conductive film, including preparing a carbon nanotube composite composition by blending a carbon nanotube in a solvent; coating the carbon nanotube composite composition on a base substrate to form a carbon nanotube composite film, and acid-treating the carbon nanotube composite film by dipping the carbon nanotube composite film in an acid solution, followed by washing the carbon nanotube composite film with distilled water and drying the washed carbon nanotube composite film to form a transparent electrode on the base substrate. The transparent conductive film can have excellent conductivity, transparency and bending properties following acid treatment, so that it can be used in touch screens and transparent electrodes of foldable flat panel displays. Further, the carbon nanotube composite conductive film can have improved conductivity while maintaining transparency after acid treatment.

Abstract: The thermoplastic resin composition of present invention comprises (A) about 50 to about 90% by weight polyphenylene sulfide resin; (B) about 5 to about 30% by weight graphite; (C) about 5 to about 30% by weight fluoropolyolefin resin; (D) about 1 to about 10% by weight whiskers; and (E) about 0.01 to about 10% by weight carbon nanotubes. The thermoplastic resin composition can exhibit electrical conductivity, wear resistance and heat resistance.

Abstract: A method for screening a substance for treating visceral adiposity syndrome comprises: (1) extracting a total RNA fraction from skeletal muscle collected from non-human mammals of a group to which a predetermined amount of the test substance has been administered and from non-human mammals of a group to which the test substance has not been administered; (2) quantifying the expression quantity of mRNA in the total RNA fraction extracted that encodes a glucose transporter gene by a specific method; and (3) comparing and analyzing the quantity of the test substance ingested, the body weight gain, and the expression quantity of RNA encoding the glucose transporter gene during the administration period for the non-human mammals of the test substance-administered group to these quantities for the non-human mammals that constitute the test substance-unadministered group to thereby determine the effect of the test substance on the metabolic syndrome.